Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4, Randomized, Open Label, Multicenter Prospective Comparative Study To Evaluate The Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure

NCT04160000 is registered in ClinicalTrials.gov with Electrophysiology Research Foundation as lead sponsor.

NCT NCT04160000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04160000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4, Randomized, Open Label, Multicenter Prospective Comparative Study To Evaluate The Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
Lead sponsor
Electrophysiology Research Foundation
Phase
Phase 4
Overall status
Unknown status
Start date
July 26, 2020
Completion date
June 30, 2025
Enrollment
360 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, diastolic heart failure, heart failure